Distinguished Speaker Seminars

Please note: Registration is free. Remember to check “auto-subscribe” when registering to automatically sign up for future seminars. Also, please bookmark our website to check for future speakers. Important: For the best viewing experience, Google Chrome is the recommended browser. Firefox and Safari also will work.

Recordings of the 2020 seminars to date are posted below.

Dec. 3, 11 a.m. EST

Stephen Urban, Ph.D., Department of Infectious Diseases, Heidelberg University Hospital

"Inhibitor of entry as a therapeutic for hepatitis B and D"

Prof. Urban is head of the Translational Virology unit at Heidelberg University Hospital and is project coordinator in the DZIF TTU Hepatitis. Prof. Urban and his team developed the first drug for hepatitis D at the Heidelberg University Hospital. The drug, which blocks the entry of the hepatitis B and hepatitis D virus into the liver cell, was approved by the European Commission on July 31.

In 2014, Prof. Urban was awarded with the DZIF Research Award and in 2011 received the Pettenkofer Price of the Pettenkofer Foundation 2011. His research interests include molecular mechanisms of hepatitis B and and hepatitis D virus/host interactions with a focus on the early and late events of viral infection; identification of hepadnaviral receptors and structural analyses of virus receptor interactions; development of novel cell culture systems and animal models for HBV and HDV; clinical development of entry inhibitors for HBV and HDV infection; development of hepatotropic drugs for the therapy of liver diseases. Prof. Urban completed his diploma in biochemistry at the University of Tübingen in 1991 and was awarded a doctorate in 1995 under Prof. Dr. P.H. Hofschneider at the Max-Planck-Institut für Biochemie, Martinsried and did postdoctoral research at the Centre for Molecular Biology, Heidelberg University, with Prof. Dr. H. Schaller. REGISTER HERE

To learn more about Dr. Urban, click here.

Dec. 10, 11 a.m. EST

Dongfang Liu, MBBS, Ph.D, Professor of Pathology, Rutgers New Jersey School of Medicine

"Natural Killer (NK) cells from basic immunobiology to clinical application"

Dongfang Liu Ph.D. To learn more about Dr. Liu, click here.

2021

Jan. 21

Prof. Ronald T. Hay, Centre for Gene Regulation and Expression, University of Dundee

"Molecular basis of arsenic treatment for acute promyelocytic leukaemia"

Feb. 4

Prof. Aleem Siddiqui, Division of Infectious Diseases and Global Public Health, University of California, San Diego

"Regulation of HBV/HCV infection by N6-methyladenosine modification"

RECENT SEMINARS

Oct. 1 - Nicholas van Buuren, Ph.D., Gilead Sciences

"Integrated HBV DNA: Investigation of the Architecture and Potential Clinical Implications."

A recording is posted here.

Sept. 13 - Rudolf K. Beran, Ph.D., Gilead Sciences

“Characterizing the interplay between hepatitis B virus X protein and Smc5/6."

A recording is posted here.

Aug. 13 - V. Narry Kim, M.S., D.Phil, Professor, Seoul National University

"Viral hijacking of host functions to protect viral RNA"

A recording is posted here.

July 16 - Andrew Vaillant, Ph.D., Chief Scientific Officer, Replicor Inc.

"Understanding HBsAg and subviral particles: key players in chronic HBV infection and key targets in achieving functional cure of HBV."

A recording is posted here.

June 30 - Marion Peters, M.D., University of California, San Francisco

Bruce Witte Distinguished Lecture, "Precision Medicine for Chronic Hepatitis B"

A recording is posted here.

June 18 - Scott L. Friedman, M.D., Icahn School of Medicine, N.Y.C.

"Mechanisms of Fibrosis Development in NAFLD and Therapeutic Strategies"

A recording is posted here.

June 4 - Mala Maini, M.D., University College, London

"Immunobiology of Chronic Hepatitis B"

A recording is posted here: